Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1.694 GBX | -0,65 % | +3,23 % | +42,95 % |
Resumen de negocios
Número de empleados: 1 164
Ventas por actividad
GBP en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Buprenorphine-based Prescription Drugs
100,0
%
| 731 | 100,0 % | 879 | 100,0 % | +20,21 % |
Ventas por región
GBP en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
83,4
%
| 593 | 81,1 % | 734 | 83,4 % | +23,63 % |
Rest of World
16,1
%
| 133 | 18,2 % | 142 | 16,1 % | +6,34 % |
United Kingdom
0,5
%
| 5 | 0,7 % | 4 | 0,5 % | -17,42 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mark Crossley
CEO | Chief Executive Officer | - | 01/01/12 |
Ryan Preblick
DFI | Director of Finance/CFO | - | 01/01/12 |
Cynthia Cetani
CMP | Compliance Officer | - | 01/10/18 |
Chief Tech/Sci/R&D Officer | - | 01/12/14 | |
Kathryn Hudson
IRO | Public Communications Contact | 50 | 15/07/15 |
Jason Thompson
IRC | Investor Relations Contact | - | - |
Vishal Kalia
PRN | Corporate Officer/Principal | - | - |
Hillel West
PRN | Corporate Officer/Principal | - | - |
Jon Fogle
HRO | Human Resources Officer | - | 01/10/14 |
Richard Simkin
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 65 | 01/11/19 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 01/06/22 |
Mark Stejbach
BRD | Director/Board Member | 61 | 24/03/21 |
Jerome Lande
BRD | Director/Board Member | 48 | 24/03/21 |
Peter Bains
BRD | Director/Board Member | 65 | 01/08/19 |
Mark Crossley
CEO | Chief Executive Officer | - | 01/01/12 |
Juliet Thompson
BRD | Director/Board Member | 57 | 24/03/21 |
Director/Board Member | 60 | 24/03/21 | |
Ryan Preblick
DFI | Director of Finance/CFO | - | 01/01/12 |
Keith Humphreys
BRD | Director/Board Member | - | 09/11 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 135 916 515 | 131 489 797 ( 96,74 %) | 0 | 96,74 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
AELIS FARMA 5.29% | 701 469 | 5.29% | 10 095 963 $ |
Información de la empresa
Indivior PLC
10710 Midlothian Turnpike Suite 125
23235, North Chesterfield
+804 379 1090
http://indivior.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
RBP Global Holdings Ltd.
RBP Global Holdings Ltd. Financial ConglomeratesFinance Part of Indivior PLC, RBP Global Holdings Ltd. is a British investment company. The private company is based in Slough, UK. RBP Global Holdings was founded in 2013. |
Financial Conglomerates
|
Sector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+42,95 % | 2910,52 M | |
+13,52 % | 9626,29 M | |
-7,87 % | 5371,28 M | |
+12,50 % | 4277,34 M | |
+18,09 % | 3711,64 M | |
-19,01 % | 2535,77 M | |
-20,66 % | 2368,35 M | |
+17,86 % | 1867,01 M | |
-0,50 % | 1644,13 M | |
-8,99 % | 1653,5 M |
- Bolsa
- Acciones
- Acción Indivior PLC - London S.E.
- Empresa Indivior PLC